What autoimmune condition is Type 1 Diabetes Mellitus (Type 1 DM) most likely associated with?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Type 1 Diabetes Mellitus and Associated Autoimmune Conditions

Autoimmune thyroid disease, particularly Hashimoto's thyroiditis (anti-TPO), is the most common autoimmune disorder associated with Type 1 Diabetes Mellitus, occurring in 17-30% of patients with Type 1 DM. 1, 2

Prevalence of Autoimmune Conditions in Type 1 DM

Autoimmune Thyroid Disease (AITD)

  • Most common autoimmune comorbidity in Type 1 DM patients 1
  • Approximately 25% of children with Type 1 DM have thyroid autoantibodies at diagnosis 1
  • Hashimoto's thyroiditis (anti-TPO antibodies) is the predominant form
  • Hyperthyroidism (Graves' disease) occurs in only about 0.5% of Type 1 DM patients 1

Celiac Disease

  • Second most common autoimmune disorder in Type 1 DM
  • Detected through anti-tissue transglutaminase (anti-TTG) antibodies 1
  • Screening recommended at diagnosis and periodically thereafter 1

Addison's Disease

  • Less common than thyroid disease and celiac disease
  • Associated with 21-hydroxylase antibodies 1
  • Part of the autoimmune polyglandular syndromes

Evidence Supporting Thyroid Disease as Most Common

  1. The 2020 American Diabetes Association guidelines explicitly state: "Autoimmune thyroid disease is the most common autoimmune disorder associated with diabetes, occurring in 17–30% of patients with type 1 diabetes" 1

  2. This is reinforced in the 2023 ADA guidelines, which maintain the same recommendation and prevalence data 1

  3. Multiple studies show higher prevalence of thyroid autoimmunity compared to other autoimmune conditions:

    • Anti-TPO antibodies found in 39.6% of Type 1 DM patients in one study 3
    • At least one thyroid antibody (anti-TPO and/or anti-TG) found in 30% of Type 1 DM patients 4

Screening Recommendations

For Thyroid Disease

  • Test for anti-thyroid peroxidase (anti-TPO) and anti-thyroglobulin antibodies soon after diagnosis 1
  • Measure TSH at diagnosis when clinically stable or after glycemic control is established 1
  • If normal, recheck every 1-2 years or sooner if:
    • Patient has positive thyroid antibodies
    • Symptoms of thyroid dysfunction develop
    • Abnormal growth rate occurs
    • Unexplained glycemic variability is present 1

For Celiac Disease

  • Screen by measuring IgA tissue transglutaminase antibodies with documentation of normal total serum IgA levels 1
  • Repeat screening within 2 years of diabetes diagnosis and again after 5 years 1

Clinical Implications

  • Thyroid dysfunction can significantly impact diabetes management:

    • Hypothyroidism may increase risk of symptomatic hypoglycemia 1
    • Hyperthyroidism typically causes deterioration of glycemic control 1
    • Patients with thyroid autoimmunity have worse glycemic control (higher HbA1c) and lipid profiles 5
  • Anti-GAD positive Type 1 DM patients have higher prevalence of thyroid autoimmunity than anti-GAD negative patients 4

  • Female patients with Type 1 DM are more likely to develop autoimmune thyroid disease than males 6, 5

Conclusion

Based on the most recent and highest quality evidence from the American Diabetes Association guidelines, Hashimoto's thyroiditis (associated with anti-TPO antibodies) is clearly the most common autoimmune condition associated with Type 1 Diabetes Mellitus, with a prevalence of 17-30%, significantly higher than celiac disease or Addison's disease.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.